BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kong XL, Lu XW, Dong SQ, Liu J, Zheng L, Chen LL, An ZH, Gao LM, Cao JL. Descending duodenal adenocarcinoma treated with pembrolizumab resulting in complete clinical response: A case report and literature review. World J Gastrointest Oncol 2025; 17(6): 107568 [PMID: 40547150 DOI: 10.4251/wjgo.v17.i6.107568]
URL: https://www.wjgnet.com/1948-5204/full/v17/i6/107568.htm
Number Citing Articles
1
Kojiro Shirabe, Tetsuro Kawazoe, Tomoya Harima, Sho Nambara, Yasuo Tsuda, Tomonori Nakanoko, Koji Ando, Eiji Oki, Tomoharu Yoshizumi. Immune Checkpoint Inhibition as a Novel Strategy for Microsatellite Instability-High Duodenal Adenocarcinoma: A Report of Three CasesSurgical Case Reports 2025; 11(1): n/a doi: 10.70352/scrj.cr.25-0645